Shanghai Haohai Biological Technology Co., Ltd. (6826.HK)
HKD 26.85
(-1.65%)
HKD 26.85
(-1.65%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 416.12 Million CNY | 130.58% |
| 2022 | 180.47 Million CNY | -48.76% |
| 2021 | 352.23 Million CNY | 53.1% |
| 2020 | 230.07 Million CNY | -37.95% |
| 2019 | 370.77 Million CNY | -10.56% |
| 2018 | 414.54 Million CNY | 11.31% |
| 2017 | 372.41 Million CNY | 22.08% |
| 2016 | 305.05 Million CNY | 11.55% |
| 2015 | 273.47 Million CNY | 48.97% |
| 2014 | 183.58 Million CNY | 29.72% |
| 2013 | 141.52 Million CNY | 24.2% |
| 2012 | 113.94 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 97.54 Million CNY | 9.21% |
| 2024 Q2 | 137.74 Million CNY | 41.21% |
| 2023 Q2 | 124.05 Million CNY | 52.82% |
| 2023 Q3 | 121.56 Million CNY | -2.01% |
| 2023 Q4 | 89.31 Million CNY | -26.53% |
| 2023 Q1 | 81.17 Million CNY | 333.63% |
| 2023 FY | 416.12 Million CNY | 130.58% |
| 2022 FY | 180.47 Million CNY | -48.76% |
| 2022 Q4 | 18.72 Million CNY | -79.36% |
| 2022 Q3 | 90.71 Million CNY | 155.44% |
| 2022 Q2 | 35.51 Million CNY | 0.0% |
| 2022 Q1 | 35.51 Million CNY | -14.91% |
| 2021 Q1 | 115.51 Million CNY | -1.63% |
| 2021 Q3 | 79.47 Million CNY | -31.2% |
| 2021 Q4 | 41.73 Million CNY | -47.48% |
| 2021 FY | 352.23 Million CNY | 53.1% |
| 2021 Q2 | 115.51 Million CNY | 0.0% |
| 2020 Q4 | 117.42 Million CNY | 37.95% |
| 2020 FY | 230.07 Million CNY | -37.95% |
| 2020 Q1 | -24.85 Million CNY | -120.76% |
| 2020 Q2 | 52.38 Million CNY | 310.75% |
| 2020 Q3 | 85.11 Million CNY | 62.5% |
| 2019 Q3 | 68.48 Million CNY | -40.95% |
| 2019 Q2 | 115.97 Million CNY | 74.16% |
| 2019 FY | 370.77 Million CNY | -10.56% |
| 2019 Q1 | 66.59 Million CNY | -34.43% |
| 2019 Q4 | 119.73 Million CNY | 74.84% |
| 2018 Q1 | 105.71 Million CNY | 7.52% |
| 2018 FY | 414.54 Million CNY | 11.31% |
| 2018 Q4 | 101.55 Million CNY | 0.0% |
| 2018 Q3 | 101.55 Million CNY | -3.93% |
| 2018 Q2 | 105.71 Million CNY | 0.0% |
| 2017 FY | 372.41 Million CNY | 22.08% |
| 2017 Q1 | 87.88 Million CNY | 14.49% |
| 2017 Q2 | 87.88 Million CNY | 0.0% |
| 2017 Q3 | 98.31 Million CNY | 11.87% |
| 2017 Q4 | 98.31 Million CNY | 0.0% |
| 2016 Q2 | 75.76 Million CNY | 0.0% |
| 2016 FY | 305.05 Million CNY | 11.55% |
| 2016 Q3 | 76.76 Million CNY | 1.32% |
| 2016 Q1 | 75.76 Million CNY | 14.28% |
| 2016 Q4 | 76.76 Million CNY | 0.0% |
| 2015 Q2 | 70.44 Million CNY | 0.0% |
| 2015 Q4 | 66.29 Million CNY | 0.0% |
| 2015 FY | 273.47 Million CNY | 48.97% |
| 2015 Q1 | 70.44 Million CNY | 38.19% |
| 2015 Q3 | 66.29 Million CNY | -5.9% |
| 2014 Q1 | 40.81 Million CNY | 12.18% |
| 2014 Q4 | 50.97 Million CNY | 0.0% |
| 2014 FY | 183.58 Million CNY | 29.72% |
| 2014 Q3 | 50.97 Million CNY | 24.9% |
| 2014 Q2 | 40.81 Million CNY | 0.0% |
| 2013 Q4 | 36.38 Million CNY | 0.0% |
| 2013 Q1 | 34.37 Million CNY | 0.0% |
| 2013 FY | 141.52 Million CNY | 24.2% |
| 2013 Q3 | 36.38 Million CNY | 5.84% |
| 2013 Q2 | 34.37 Million CNY | 0.0% |
| 2012 FY | 113.94 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 70.87 Million HKD | -487.111% |
| CK Life Sciences Int'l., (Holdings) Inc. | 17.25 Million HKD | -2312.296% |